After its latest device struggled to perform, brain-computer interface startup Synchon halted clinical trials. The company says it will upgrade the implant’s hardware and is at work on a new device.

Radical Numerics has developed a model that it says can identify natural and AI-engineered pathogens without an internet connection.

Researchers in Germany gradually reversed human cells’ ages by decades. By doing so, they could track the de-aging process in a way previous rejuvenation experiments could not.

The key to the movement of these flexible robots is the algae’s photosynthetic capabilities.

The company’s cofounder recently convinced the Trump administration to support an initiative to gather DNA samples from endangered species.

A biotech startup let an agent choose a gene therapy and successfully inject the treatment, offering a startling glimpse of the future of research labs.

In breathless press releases and posts, the company has touted its models’ ability to deliver scientific breakthroughs. But its IPO filing taps the brakes on just how fast its AI will lead to big discoveries.

This week on “Uncanny Valley,” we go behind the scenes of our Nathan Fielder cover story, unpack tech billionaires’ generous promises, and discuss the suspicious letters sent to US election offices.

It’s the latest in a growing wave of bets that AI companies are making on brain data.